L Levy, C C Shepard, P Fasal. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh： See more » Administration, OralAdultAgedAniline Compounds/administration & dosageAniline Compounds/pharmacologyAniline Compounds/therapeutic useAnimalsBiopsyDapsone/administration & dosageDapsone/pharmacologyDapsone/therapeutic useDrug Resistance, MicrobialFemaleFootHumansLeprosy/drug therapyLeprosy/microbiologyLeprosy/pathologyMaleMethodsMiceMiddle AgedMycobacterium leprae/drug effectsMycobacterium leprae/isolation & purificationPhenazines/administration & dosagePhenazines/pharmacologyPhenazines/therapeutic useSkin/microbiologyTime Factors
Substances： See more » Aniline CompoundsPhenazinesDapsone
Year: 1972 PMID： 4554496 DOI： 10.4269/ajtmh.1972.21.315
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN： 0002-9637 Impact factor: 2.345